Testimony of Herman Jenich

National Committee on Vital and Health Statistics

Thursday, September 16, 1999

IPRO
Corporate Headquarters
Managed Care Department
1979 Marcus Avenue, First Floor
Lake Success, NY 11042-1002
516-326-7767 · 516-326-6177 [Fax]


Introduction

Good morning. My name is Herman Jenich, and I am the Associate Vice President for Managed Care at IPRO. IPRO serves as the Medicare Peer Review Organization for the State of New York, holds Medicaid oversight contracts in several states, and provides a variety of services to commercial insurers, unions, and managed care plans. Through its work with these clients, IPRO has gained extensive experience in evaluating the quality of health care, as well as the adequacy of health care data.

I am delighted to have been asked to discuss how some of the lessons that IPRO has learned can assist the National Committee on Vital and Health Statistics in its efforts to develop recommendations for how to best facilitate the development of electronic standards for Patient Medical Record Information (PMRI). As I am responsible for leading the design and implementation of a wide range of IPRO studies that evaluate health plan processes and outcomes, most of the information I will be presenting today is based on IPRO’s work in the managed care area. In general, IPRO’s work with health plans can be divided into three categories:

The material that I am presenting today will draw upon IPRO’s experience with health plans in each of these three areas.

Overview

In my testimony, I will address three questions that currently confront the Committee as it develops its recommendations:

  1. Why do we need comparable PMRI?
  2. What are some of the system limitations that currently hinder health care data quality?
  3. What are some issues that government and industry may want to address collaboratively in their development of PMRI standards?

I will spend the remainder of my time this morning providing what I hope is useful information to help the Committee answer each of these questions.

1. Why do we need comparable PMRI?

Comparable PMRI is fundamental to the ability of health plans, individual practitioners, and health care purchasers to ensure the value of health care delivered to patients. Without comparable PMRI, health care payers and providers cannot fully assess effectiveness, timeliness, access, and other important attributes of health services. For example, most health care organizations identify areas for improvement in relationship to particular goals, benchmarks, or trends. Without comparable PMRI among organizations and across time, efforts to improve the quality of care are hampered, as health plans and practitioners may draw misguided conclusions and fail to identify those areas most in need of improvement.

Currently, however, comparable PMRI is difficult and costly to obtain, since compiling full PMRI generally involves combining two sources of information: electronic administrative data and paper patient records. Health plans collect much of their electronic administrative data for purposes of billing, not performance measurement or quality improvement. Although administrative data is somewhat useful for process or outcome measurement, it is often inadequate to fully measure a health plan’s or an individual practitioner’s performance. Paper medical records have often been considered the “gold standard” of medical record information, but in many of the encounter data validation and quality improvement studies that we have conducted, we find that the medical record does not contain some of the information that has been documented in administrative data. In addition, paper records are very costly to retrieve and review, and intensive oversight must be used to ensure the validity of judgments made while abstracting data from paper records.

Even when health plans take great care to accurately process administrative data and consistently review medical records, the resulting performance rates may still not be accurate or consistent across health plans. Determining the maximum amount of acceptable bias depends, largely, on the needs of those using the data and the ability of validation techniques to detect differences among health care organizations. For example, NCQA, as part of its HEDIS Compliance AuditÔ process, requires that rates expressed as a percentage be biased by no more than 5 percentage points. While this level of specificity is generally acceptable to the users of HEDIS data, validating rates produced by multiple health plans with widely disparate systems and processes to this level of accuracy is challenging and often relies on auditor judgment rather than definitive data. The following section of this testimony describes some of these disparate systems and processes and their effect on health care data quality.

2. What are some of the system limitations that currently hinder health care data quality?

Through IPRO’s work in HEDISÒ auditing, encounter data validation, and quality improvement studies, we have identified those data system limitations that commonly preclude accurate measurement of health plan and individual practitioner performance. Below, we list and briefly describe each of these limitations. For ease of review, each limitation has been placed into one of five categories: clinical data, membership data, provider data, vendor data, and data integration.

Clinical Data (i.e., Claims/Encounter Data)

Membership Data

Provider Data

Vendor Data

Health plans often rely on vendors for a wide variety of ancillary services (e.g., pharmacy, laboratory, behavioral health, home health, eye care). Vendors are sometimes also used for basic health plan functions, such as processing claims and encounters or maintaining membership or provider data. Often, however, health plans are not able to use vendor data for performance measurement purposes because:

Data Integration

For a variety of reasons mentioned above, health plans often have difficulty consolidating the claims, encounter, membership, provider, and vendor data required for performance measurement. Health plans that have multiple systems for each of these data types—as well as those that have recently undergone a merger, acquisition, or significant system upgrade—have the greatest difficulties. Each additional system from which data must be acquired increases the likelihood that the health plan will encounter incompatible coding schemes, different member and provider identifiers, and other data consolidation difficulties.

Almost all health plans are continually working to improve their ability to efficiently capture and integrate health care data that can be used for performance measurement and quality improvement activities. At this time, however, many health plans can only conduct relatively simple assessments of the effectiveness of health care if they rely solely on data that is available electronically. For comprehensive analyses of the care provided for diabetes, asthma, and other important diseases, health plans generally rely at least in part on abstraction of information from paper medical records.

3. What are some issues that government and industry may want to address collaboratively in their development of PMRI standards?

As stated several times in this testimony, health plans often cannot easily access accurate and complete PMRI. This hinders the ability of health plans and purchasers to measure outcomes, quality, and performance. The list of current system limitations is long; while some of these limitations could be addressed during the next several years, others are likely to be solved only through long-term collaboration by government agencies, employers, health plans, hospitals, individual practitioners, and quality standards organizations like NCQA and JCAHO. As part of their collaborative approach, these individuals and organizations may want to consider the following:

The development of standards for electronic PMRI will assist both health care purchasers and providers in their efforts to measure health plan performance. In addition, the PMRI standards will likely encourage the development of fully automated medical record keeping and, thereby, eliminate the need for costly abstraction from paper medical records to support performance measurement. Finally, for any electronic PMRI effort to be successful, government agencies and the private sector will both need to be active participants in the standards development and implementation process.

That concludes my comments for this morning. I look forward to responding to any questions that Committee members may have.